✦ LIBER ✦

Preliminary results from a Phase II trial of EPO906 in patients with advanced refractory ovarian cancer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II Study of Patupilone (EPO906)

✍ Smit, Willem M.; Šufliarsky, Jozef; Werner, Theresa L.; Dizon, Don S.; Wagnerová 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 140 KB

Docetaxel in advanced ovarian cancer: Pr

✍ S.B. Kaye; M. Piccart; M. Aapro; J. Kavanagh 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 329 KB

Phase II trial of intravenous hexamethyl

✍ Mark D. Hauge; Harry J. Long; Lynn C. Hartmann; John H. Edmonson; Maurice J. Web 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 192 KB

Phase II clinical trial of doxifluridine

✍ van Oosterom, A.T.; ten Bokkel Huinink, W.W.; van der Burg, M.E.L.; Vermorken, J 📂 Article 📅 1991 🏛 Elsevier Science ⚖ 412 KB

Preliminary results of a phase I/II tria

✍ C. Bokemeyer; H. -J. Schmoll; F. Natt; M. Knoche; J. Beyer; R. Souchon 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 387 KB

A phase II trial of a paclitaxel and oxa

✍ Viens, P.; Bougnoux, P.; Rixe, O.; Petit, T.; Laadem, A.; Cottu, P.; Delva, R.; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 186 KB